EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Methylprednisolone as Adjunct to Thrombectomy for Acute Intracranial Internal Carotid Artery Occlusion Stroke

Chong Zheng, Rongtong Li, Chaoxiong Shen, Fang Guo, Daofeng Fan, Lixian Yang, Li Zhang, Anni Chen, Yangui Chen, Dongping Chen, Wenjie Zi, Changwei Guo und 5 weitere

JAMA Network Open · 18.02.2025 · 8 (2) · e2459945

DOI: 10.1001/jamanetworkopen.2024.59945 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, online erschienen am 18.02.2025. Verfasst von Chong Zheng und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China. Hauptthemen laut MEDLINE: Methylprednisolone, Thrombectomy, Ischemic Stroke. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Patients with acute ischemic stroke (AIS) due to intracranial internal carotid artery (ICA) occlusion often have poor functional outcomes despite undergoing endovascular thrombectomy (EVT).

Objective

To investigate the effectiveness and safety associated with intravenous methylprednisolone as adjunctive treatment to EVT for patients with AIS due to intracranial ICA occlusion. Design, Setting, and Participants This was a post hoc analysis of the MARVEL randomized, double-blind, placebo-controlled clinical trial conducted from February 9, 2022, to June 30, 2023, at 82 stroke centers across China with a 3-month follow-up. The primary trial enrolled 1680 patients with large vessel occlusion within 24 hours from last known well time in the intracranial ICA, the first segment of the middle cerebral artery (M1), or the second segment of the middle cerebral artery (M2), of whom 579 patients had intracranial ICA occlusion.

Intervention

Intravenous methylprednisolone, 2 mg/kg/d (maximum dose, 160 mg) for 3 days plus EVT vs placebo plus EVT. Main Outcomes and Measures The primary outcome was independent ambulation at 90 days, defined as a score of 0 to 3 on the modified Rankin Scale (range, 0 [no symptoms] to 6 [death]). Safety outcomes included death within 90 days, symptomatic intracranial hemorrhage (sICH) within 48 hours, and decompressive hemicraniectomy to relieve midline-shift and intracranial pressure after EVT.

Results

Among 579 patients (median age, 69.0 years [IQR, 59.0-76.0 years]; 338 men [58.4%]), there were 286 patients in the methylprednisolone group and 293 patients in the placebo group. The proportion of patients who achieved 90-day independent ambulation was significantly higher in the methylprednisolone group than in the placebo group (151 of 284 [53.2%] vs 125 of 293 [42.7%]; adjusted risk ratio [RR], 1.27 [95% CI, 1.07-1.52]; P = .007). The incidence of sICH was lower in the methylprednisolone group than in the placebo group (26 of 277 [9.4%] vs 45 of 290 [15.5%]; adjusted RR, 0.55 [95% CI, 0.35-0.87]; P = .01). The rate of decompressive hemicraniectomy was lower in the methylprednisolone group compared with the placebo group (16 of 286 [5.6%] vs 29 of 293 [9.9%]; adjusted RR, 0.54 [95% CI, 0.30-0.98]; P = .04). No significant difference was observed in mortality between groups (methylprednisolone, 92 of 284 [32.4%] vs placebo, 111 of 239 [37.9%]; adjusted RR, 0.84 [95% CI, 0.67-1.05]; P = .13). Conclusions and Relevance In this secondary analysis of a randomized clinical trial of intravenous methylprednisolone vs placebo for patients with intracranial ICA occlusion undergoing EVT, intravenous methylprednisolone was associated with improved ambulation. These findings suggest that the use of intravenous methylprednisolone as an adjunct to EVT may hold promise as a treatment option for patients with AIS due to intracranial ICA occlusion.

Trial registration

ChiCTR.org.cn Identifier: ChiCTR2100051729

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylprednisoloneThrombectomyIschemic StrokeHumansMaleFemaleMiddle AgedAgedDouble-Blind MethodTreatment OutcomeCarotid Artery, InternalChina

Substanzen

Methylprednisolone

Autor:innen und Institutionen

  • Department of Neurology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
  • Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Department of Neurology, Boston Medical Center, Boston, Massachusetts.
  • Department of Radiology, Boston Medical Center, Boston, Massachusetts.
  • Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Palo Alto, California.
  • Department of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.

Zitieren

APA

Zheng, C., Li, R., Shen, C., Guo, F., Fan, D., Yang, L., Zhang, L., Chen, A., Chen, Y., Chen, D., Zi, W., Guo, C., Nguyen, T. N., Albers, G. W., Campbell, B. C. V., Qiu, Z., & Hu, Z. (2025). Methylprednisolone as Adjunct to Thrombectomy for Acute Intracranial Internal Carotid Artery Occlusion Stroke. JAMA Network Open, 8(2), e2459945. https://doi.org/10.1001/jamanetworkopen.2024.59945

Vancouver

Zheng C, Li R, Shen C, Guo F, Fan D, Yang L, et al. Methylprednisolone as Adjunct to Thrombectomy for Acute Intracranial Internal Carotid Artery Occlusion Stroke. JAMA Network Open. 2025;8(2):e2459945. doi:10.1001/jamanetworkopen.2024.59945

BibTeX
@article{Zheng2025,
  author = {Zheng, Chong and Li, Rongtong and Shen, Chaoxiong and Guo, Fang and Fan, Daofeng and Yang, Lixian and Zhang, Li and Chen, Anni and Chen, Yangui and Chen, Dongping and Zi, Wenjie and Guo, Changwei and Nguyen, Thanh N and Albers, Gregory W and Campbell, Bruce C V and Qiu, Zhongming and Hu, Zhizhou},
  title = {Methylprednisolone as Adjunct to Thrombectomy for Acute Intracranial Internal Carotid Artery Occlusion Stroke},
  journal = {JAMA Network Open},
  year = {2025},
  volume = {8},
  number = {2},
  pages = {e2459945},
  doi = {10.1001/jamanetworkopen.2024.59945}
}
Kostenlos starten →